TYRA · Tyra Biosciences Inc
United States · RS rating 38 · As of 2026-11-03
| Price | 21.37 USD |
|---|---|
| 1-day change | +0.2% |
| RS rating (overall / 1M / 3M / 12M) | 38 / 64 / 35 / 78 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 17 / 13 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -14.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +46.0% |
| Market cap (USD) | $2.2B |